Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts

Fig. 3

Assessment of proliferation, apoptosis and microvessel density. (a) Mitotic activity assessed by H&E staining and pHH3 immunostaining. (b) Apoptotic activity assessed by H&E staining and cleaved PARP immunostaining. (c) Microvessel density assessed by CD31 immunostaining. *p < 0.05, **p < 0.005 as compared to control; #p < 0.05, ##p < 0.005 as compared to doxorubicin monotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us